Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Mulls Granting Regulated Industry Flexibility To Respond To Misinformation
Jan 11 2023
•
By
Sarah Karlin-Smith
FDA Commissioner Califf hints at more permissive sponsor communication to address misinformation • Source: Shutterstock
More from Marketing & Advertising
More from Compliance